Mechanisms underlying the cytotoxic effects of Tachpyr—a novel metal chelator
- 24 April 2002
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1571 (3) , 211-218
- https://doi.org/10.1016/s0304-4165(02)00218-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Oxidative stress as a mediator of apoptosisPublished by Elsevier ,2002
- Iron chelation: New therapiesSeminars in Hematology, 2001
- Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)Transfusion Science, 2000
- Therapy by taking away: the case of ironBiochemical Pharmacology, 1999
- Iron Chelators for ThalassaemiaBritish Journal of Haematology, 1998
- The Shape of Cell DeathBiochemical and Biophysical Research Communications, 1997
- The biochemistry of programmed cell deathThe FASEB Journal, 1995
- Iron chelation therapyCurrent Opinion in Hematology, 1995
- Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferationBlood, 1984
- Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.Proceedings of the National Academy of Sciences, 1982